Letter: should immunosuppressive therapy be started with adalimumab in Crohn's disease? Authors' reply

Aliment Pharmacol Ther. 2013 Apr;37(7):752-3. doi: 10.1111/apt.12245.
No abstract available

Publication types

  • Letter
  • Comment

MeSH terms

  • Antibodies, Monoclonal, Humanized / therapeutic use*
  • Crohn Disease / drug therapy*
  • Female
  • Humans
  • Immunosuppressive Agents / therapeutic use*
  • Male
  • Tumor Necrosis Factor-alpha / antagonists & inhibitors*

Substances

  • Antibodies, Monoclonal, Humanized
  • Immunosuppressive Agents
  • Tumor Necrosis Factor-alpha